Mar 7Function Therapeutics receives Phase 1 SBIR Award from NSFFunction Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the U.S. National Science...
Dec 12, 2022UNC researchers report protective effects of parmodulins in sickle cell disease modelsA collaborative team led by Prof. Erica Sparkenbaugh from the Univ. of North Carolina Blood Research Center reported at the 64th American...
Nov 12, 2022Peter Suzdak, Ph.D. joins as consultantPeter Suzdak, Ph.D. has joined Function Therapeutics, Inc. as a consultant. Dr. Suzdak has deep scientific and management successes in...
